Wednesday 30 September 2009

Pirazinid




Pirazinid may be available in the countries listed below.


Ingredient matches for Pirazinid



Pyrazinamide

Pyrazinamide is reported as an ingredient of Pirazinid in the following countries:


  • Bosnia & Herzegowina

  • Turkey

International Drug Name Search

Thursday 24 September 2009

Spersallerg




Spersallerg may be available in the countries listed below.


Ingredient matches for Spersallerg



Antazoline

Antazoline is reported as an ingredient of Spersallerg in the following countries:


  • Slovenia

Antazoline hydrochloride (a derivative of Antazoline) is reported as an ingredient of Spersallerg in the following countries:


  • Bulgaria

  • Germany

  • Norway

  • Oman

  • Poland

  • Slovakia

  • South Africa

  • Switzerland

Tetryzoline

Tetryzoline is reported as an ingredient of Spersallerg in the following countries:


  • Slovenia

Tetryzoline hydrochloride (a derivative of Tetryzoline) is reported as an ingredient of Spersallerg in the following countries:


  • Bulgaria

  • Germany

  • Norway

  • Oman

  • Poland

  • Slovakia

  • South Africa

  • Switzerland

International Drug Name Search

Monday 21 September 2009

Sitaxentan




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C02KX03

CAS registry number (Chemical Abstracts Service)

0184036-34-8

Chemical Formula

C18-H15-Cl-N2-O6-S2

Molecular Weight

454

Therapeutic Category

Endothelin antagonist

Chemical Names

N-(4-Chlor-3-methylisoxazol-5-yl)-2-[(4,5-methylendioxy-2-methylphenyl)acetyl]thiophen-3-sulfonamid (IUPAC)

N-(4-Chlor-3-methylisoxazol-5-yl)-2-[2-(6-methyl-1,3-benzodioxol-5-yl)acetyl]thiophen-3-sulfonamid

N-(4-Chloro-3-methyl-5-isoxazolyl)-2-[[4,5-(methylenedioxy)-o-tolyl]acetyl]-3-thiophenesulfonamide (WHO)

3-Thiophenesulfonamide, N-(4-chloro-3-methyl-5-isoxazolyl)-2-[[6-methyl-1,3-benzodioxol-5-yl]acetyl]-

Foreign Names

  • Sitaxentanum (Latin)
  • Sitaxentan (German)
  • Sitaxentan (French)
  • Sitaxentan (Spanish)

Generic Names

  • IPI 1040 (IS)
  • Sitaxsentan (IS)
  • LGLS (IS)
  • TBC-11241 (IS)
  • TBC-11251 (IS: TexasBiotechn)
  • TBC-2576 (IS)
  • TBC-3214 (IS)

Brand Names

  • Thelin
    Praxis Pharmaceutical, Spain; CSL, Australia; Encysive, Austria; Encysive, Germany; Encysive, France; Encysive, United Kingdom; Encysive, Ireland; Encysive, Luxembourg; Encysive, Netherlands; LCA, Belgium; EncysiveUK Limited, Denmark


  • THELIN
    Pfizer, Sweden

International Drug Name Search

Glossary

IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday 20 September 2009

Renitab




Renitab may be available in the countries listed below.


Ingredient matches for Renitab



Ranitidine

Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Renitab in the following countries:


  • Myanmar

International Drug Name Search

Saturday 19 September 2009

Loratadina Farmindustria




Loratadina Farmindustria may be available in the countries listed below.


Ingredient matches for Loratadina Farmindustria



Loratadine

Loratadine is reported as an ingredient of Loratadina Farmindustria in the following countries:


  • Peru

International Drug Name Search

Monday 14 September 2009

Decavac


Generic Name: diphtheria and tetanus vaccine (Intramuscular route)


dif-THEER-ee-a TOX-oyd, ad-SORBD, TET-n-us TOX-oyd


Commonly used brand name(s)

In the U.S.


  • Decavac

Available Dosage Forms:


  • Suspension

Therapeutic Class: Vaccine


Uses For Decavac


Diphtheria and tetanus vaccine is a combination vaccine that is given to protect against infections caused by diphtheria and tetanus (lockjaw). The vaccine works by causing the body to produce its own protection (antibodies) against these diseases. This vaccine is given to children 6 weeks of age and older, teenagers, and adults.


Diphtheria is a serious illness that can cause breathing problems, heart problems, nerve damage, pneumonia, and possibly death. The risk for serious illness is greater in very young children and the elderly.


Tetanus (also known as lockjaw) is a very serious illness that causes severe muscle spasms that make the muscles very rigid or stiff. The muscle spasms can be strong enough to cause bone fractures in the spine. The disease can also cause breathing problems, swallowing problems, seizures, and possibly death.


This vaccine is to be administered only by or under the direct supervision of a doctor.


Before Using Decavac


In deciding to use a vaccine, the risks of taking the vaccine must be weighed against the good it will do. This is a decision you and your doctor will make. For this vaccine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of Diphtheria and Tetanus Toxoids Vaccine for Pediatric Use in children 7 years of age and older. Safety and efficacy have not been established.


Appropriate studies have not been performed on the relationship of age to the effects of Decavac® vaccine in children younger than 7 years of age. Safety and efficacy have not been established.


Geriatric


Although appropriate studies on the relationship of age to the effects of Decavac® vaccine have not been performed in the geriatric population, no geriatric-specific problems have been documented to date.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this vaccine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Allergic reaction to a tetanus vaccine (eg, Arthus-type reaction) or

  • Guillain-BarrĂ© syndrome (nerve disease that causes paralysis) after a tetanus vaccine, history of—Your doctor will decide if you should receive this vaccine.

  • Immunodeficiency disorder (low blood counts for white cells or platelets) or

  • Weakened immune system—May not work as well in patients with these conditions.

Proper Use of Decavac


A nurse or other trained health professional will give you or your child this vaccine. This vaccine is given as a shot into one of your muscles, usually in the upper leg for infants or in the shoulder for older children, teenagers, and adults.


Depending on the age of the child, this vaccine is given as a series of 3 or 4 doses. Teenagers and adults will receive a total of 3 doses.


After the first set of shots, you or your child should get a booster shot every 10 years.


It is important that you or your child receive all of the doses of vaccine in this series. Try to keep all of your scheduled appointments. If you miss a dose, make another appointment as soon as possible.


Precautions While Using Decavac


It is very important that you or your child return to your doctor’s office at the right time for the next dose. Be sure to notify your doctor of any unwanted effects that occur after you receive the vaccine.


If you or your child develop a skin rash, hives, or any allergic reaction after receiving this vaccine, tell your doctor right away.


Tell your doctor right away if you or your child are allergic to latex rubber. The prefilled syringes or bottle of vaccine may contain natural rubber latex. This may cause an allergic reaction in patients who are sensitive to latex.


This vaccine will not treat an active infection. If you or your child have an infection due to diphtheria or tetanus, you will need medicine to treat the infection.


Decavac Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor or nurse immediately if any of the following side effects occur:


Less common
  • Fever

  • general feeling of discomfort or illness

  • unusual tiredness or weakness

Incidence not known
  • Bloating or swelling of the face, arms, hands, lower legs, or feet

  • burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings

  • chills

  • convulsions

  • cough

  • difficulty with swallowing

  • dizziness

  • fainting

  • fast heartbeat

  • hives

  • itching

  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue

  • rapid weight gain

  • shortness of breath

  • skin rash

  • swelling or puffiness of the face

  • swollen, painful, or tender lymph glands in the neck, armpit, or groin

  • tightness in the chest

  • tingling of the hands or feet

  • unusual weight gain or loss

  • wheezing

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Hard lumps, redness, tenderness, or warmth at the injection site

Less common
  • Headache

Incidence not known
  • Difficulty with moving

  • joint pain

  • lack or loss of strength

  • muscle aching or cramping

  • muscle stiffness

  • nausea

  • pain in the arms or legs

  • swollen joints

  • vomiting

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Decavac side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Decavac resources


  • Decavac Side Effects (in more detail)
  • Decavac Use in Pregnancy & Breastfeeding
  • Decavac Drug Interactions
  • 0 Reviews for Decavac - Add your own review/rating


Compare Decavac with other medications


  • Diphtheria Prophylaxis
  • Tetanus Prophylaxis

Thursday 10 September 2009

Irufen




Irufen may be available in the countries listed below.


Ingredient matches for Irufen



Ibuprofen

Ibuprofen is reported as an ingredient of Irufen in the following countries:


  • Bangladesh

International Drug Name Search

Monday 7 September 2009

Triject




Triject may be available in the countries listed below.


Ingredient matches for Triject



Ceftriaxone

Ceftriaxone is reported as an ingredient of Triject in the following countries:


  • Bangladesh

International Drug Name Search

Thursday 3 September 2009

Sertra Basics




Sertra Basics may be available in the countries listed below.


Ingredient matches for Sertra Basics



Sertraline

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertra Basics in the following countries:


  • Germany

International Drug Name Search